Chronic oedema: a prevalent health care problem for UK health services by Moffatt, Christine J. et al.
1 
 
Accepted (minor revisions) International Wound Journal  
Running title:  Chronic Oedema in UK Health Services 
 
 
 
Chronic Oedema:   a Prevalent Health Care Problem for UK Health Services 
 
C. J. Moffatt1  
V. Keeley2,3  
P. J. Franks4,5  
A. Rich 2 
L. L. Pinnington 5  
 
1. School of Health Sciences, University of Nottingham, Royal Derby Hospital Centre, 
Derby DE22 3DT  
2. Department of Lymphoedema Service, Division of Medicine and Cancer, Derby 
Teaching Hospitals NHS Foundation Trust, Derby DE22 3NE 
3. University of Nottingham, Royal Derby Hospital Centre, Derby DE22 3DT  
4. Centre for Research & Implementation of Clinical Practice, London SW15 6NP 
5. Faculty of Medicine, Division of Nursing and Healthcare, University of Glasgow, 
Glasgow G12 8LW School of Medicine,  
 
 
 
Address for correspondence 
Professor Peter J Franks,  
Centre for Research & Implementation of Clinical Practice,  
128 Hill House 
210 Upper Richmond Road 
London SW15 6NP 
 
Peter.franks@cricp.org.uk 
 
07817196647 
 
2 
 
Summary 
Chronic oedema is a major clinical problem worldwide, which has many important secondary 
consequences for health, activity and participation. Effective treatment planning and 
organisation of services is dependent on an understanding of the condition and its 
epidemiology.  This cross sectional study was designed to estimate the point prevalence of 
chronic oedema within the health services of one UK urban population and to determine the 
proportions that have concurrent leg ulceration. 
Patients with chronic oedema were ascertained by health care professionals in one acute and 
one community hospital, all relevant out-patient and community nursing services, general 
practices and all nursing/residential homes in one urban catchment area (Derby City).  The 
presence and distribution of oedema was confirmed through a brief clinical examination.  A 
battery of demographic and clinical details was recorded for each case.   
Within the study population of Derby City residents, 971 patients were identified with chronic 
oedema (estimated crude prevalence 3.93 per 1,000, 95% CI 3.69-4.19).  The prevalence was 
highest amongst those aged 85 or above (28.75 per 1,000) and was higher amongst women 
(5.37 per 1,000) than men (2.48 per 1,000).  The prevalence amongst hospital in-patients was 
28.5%. Only 5 (3%) patients in the community population had oedema related to cancer or 
cancer treatment.  Of the 304 patients identified with oedema from the Derby hospitals or 
community health services 121 (40%) had a concurrent leg ulcer. 
Prevalence statistics and current demographic trends indicate that chronic oedema is a major 
and growing health care problem. 
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Introduction 
Chronic oedema (CO) is a major clinical problem worldwide which has many important 
secondary consequences [1].   The term ‘chronic oedema’ is now commonly used in place of 
‘lymphoedema’ as this encompasses all forms of oedema which persist for three months, 
irrespective of the aetiology [2].  CO is associated with many long term conditions such as 
cancer and diabetes.  It is also related to reduced mobility and obesity, both of which are 
expected to escalate exponentially over the next 10-15 years due to population ageing [3,4]. 
Although CO has potentially life threatening consequences, the prevalence and impact of the 
problem remains poorly understood.  
To date, the focus of previous research has been to estimate prevalence in specific patient 
groups [5, 6] however, since CO is the final common pathway for many conditions, it is 
important that prevalence is examined amongst heterogeneous populations.  One earlier 
study of a mixed London based population, estimated the prevalence of CO to be 1.33 per 
1,000 [2].   
 
In order to understand the current scale of this health care problem, this study was designed 
to estimate the point prevalence and impact of CO amongst a heterogeneous population within 
the health services of one urban geographical area of the UK and to determine the proportions 
that have concurrent leg ulceration. 
Methods 
Setting and Sampling Frame 
This cross sectional study was carried out in Derby City (UK) which has a population of 
approximately 247,100.   Data were obtained from ten sources, namely:  the in-patients of one 
acute and one community hospital, one specialist and three non-specialist out-patient clinics 
(dermatology, plastic surgery and diabetic foot clinic), all community nursing services, general 
practices (n=41) and nursing/residential homes (n=26) in the Derby City catchment area. 
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Case Ascertainment and Inclusion Criteria 
People with CO were identified initially by an observational ‘Pitting Oedema Test’ [7].  The 
procedure has been shown to be valid and reliable [8] and is widely used in clinical practice.  
The test is carried out by pressing the thumb into the site of the swelling for 10 seconds.   A 
positive result is indicated if a ‘pit’ remains following removal of pressure.   
Oedema was judged to be chronic if it had been present for three months or more.  Participants 
were also selected on the basis of the following criteria: 
• children and adults of both genders and of any age or ethnicity 
• patients who were residents of Derby City (as determined by home postcode)  
• all patients accessible to staff for CO screening (this excluded patients in theatre, 
intensive care or maternity suites) 
 
Core Data Set 
The following core data set was collected for all patients identified with CO during March 2012:   
 demographic details  
 presence, site and history of CO, cellulitis (reported during the last six months) and leg 
ulceration (recorded for all body parts using a body map) 
 presence and site of cancer related CO (or cancer treatment related CO)  
 treatment currently received for CO 
 
These data were collected using a standard questionnaire, the development of which has 
been described in full previously [2] and which is available on request. The feasibility of 
adopting the questionnaire in this setting was piloted initially to ensure the content was clear 
and the data could be completed in the time available.  In all settings, clinicians were trained 
in the use of the questionnaire and the Pitting Test. 
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Data Collection Procedures 
Staff in each case ascertainment setting screened all patients who consented to participate 
irrespective of the underlying disease or treatment regimen.  A unique patient identification 
code was issued per person to avoid ‘double counting’ and all questionnaires were pre-printed 
with participant ID numbers.  Master identifier lists were retained by each service manager to 
ensure anonymity was maintained and for data protection purposes. 
 
Approval for the project was granted by the Research and Innovation Department of the Royal 
Derby Hospital, the Trust data protection and senior management teams.  
 
The types and sources of data collected in each setting, the services contacted and the 
respective response rates are summarised in Tables 1 and 2.    
 
Hospital in-Patients 
All in-patients present at Royal Derby Hospital and London Road Community Hospital during 
a 48 hour period were reviewed for eligibility.   
 
Patients were examined clinically to determine the presence of CO and this was repeated by 
a second independent assessor, to check the reliability of information obtained.  Other core 
data were recorded using the questionnaire described above.  
 
 
 
Specialist and Non-Specialist Out-Patient Services  
The lymphoedema service database was searched to identify current patients who met the 
inclusion criteria. Additional information about BMI and aetiology were also recorded. 
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Patients attending non-specialist but related clinics were examined during a five day period to 
determine if they met the inclusion criteria.  Clinic staff completed a questionnaire for each 
patient and undertook the clinical screening test. 
 
Community Nursing Services and GP Practices 
Clinicians in all community nursing teams and GP practices were asked to complete one 
questionnaire for each patient who met the inclusion criteria.  Clinicians who did not respond 
initially were contacted one month later. 
 
Nursing and Residential Homes 
The managers of all social service and privately funded nursing and residential homes were 
asked to complete a questionnaire for each resident who met the inclusion criteria. Completed 
questionnaires were collected by the lead for tissue viability in community nursing services.   
Non responders were contacted one month later. 
 
Data Analysis 
Data quality checks were made by designated managers in each participating service.  A study 
monitor carried out additional quality checks.  
 
All data were imported into Stata 11 where descriptive statistics were undertaken.  Age and 
gender specific rates were calculated based on the resident population.  Direct standardisation 
was undertaken using a standard population of primary care organisations in England in 2010 
to compare the rates from Derby and a previous study using similar methodology [2]. 
 
Results 
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Prevalence of Chronic Oedema in Derby City 
In all, 992 patients living in Derby City were identified from the services studied.  Of these, 21 
patients did not have CO but were thought to be at risk of its development and were removed 
from the analysis.  The remaining 971 patients had CO of greater than 3 months duration 
(Table 3). The mean age (SD) was 68.5 (16.5) years. The total crude prevalence was 
3.93/1,000 population (95% CI 3.69-4.19) with a prevalence of 2.48 for men and 5.37 for 
women. There was an age gradient with a prevalence of 10.31 /1,000 in those aged over 65 
to 74 rising further to 28.75 in those aged over 85 years of age. 
 
Prevalence of Chronic Oedema and Leg Ulceration  
Amongst the in-patient population, 453 people were assessed and this revealed that 129 
(28.5%) people had CO.   Twenty nine people in this group also had leg ulceration (22.5%).  
Amongst the community population, 175 patients were identified with swelling of whom 92 
(52.6%) also had leg ulceration.   
 
Proportion and Characteristics of Out-Patients Managed by the Specialist 
Lymphoedema Service  
From the total population (n=971) of patients identified, 667 (69%) were being managed by 
the Specialist Out-Patient Lymphoedema Service.  Four hundred and eighty nine people in 
this group were women (73%). 
Based on the standard classification system used in this service, the largest patient group was 
found to have secondary oedema (n=246, 38%), followed by obesity and/or reduced mobility 
(n=169, 26%) (Table 4).  Primary lymphoedema was diagnosed amongst 80 patients (12%).   
A large proportion of patients for whom a BMI was available were obese or morbidly obese 
(n=251/361, 69.5%) (Table 5).  The mean (SD) BMI was 35.5 (9.9) kg/m2.  The indices fell 
within the obese range (Class I and II) for 44% of the group, with a further 25% in Class III.  
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Cancer and Cellulitis 
Only a minority of patients in the hospital in-patient (n=5, 4%) and community (n=5, 3%) setting 
had CO associated with cancer.  Cellulitis was a common co-morbidity amongst community 
based patients with 105/175 (60%) having experienced at least one episode during the 
previous six months.  Of these 23 (22%) people had been admitted to hospital for treatment 
of the infection.  A total of 232 infections had been recorded for this patient group.   
 
Discussion 
Attempts to define the prevalence of CO in the general population are sparse [9] and most 
previous studies have relied on information which has been obtained from specific patient 
groups [5, 6, 10].  This study shows that the point prevalence of CO in a heterogeneous health 
service population is high and comparable to or greater than the prevalence of other serious 
long term conditions such as stroke.  Patients were identified in all age categories and 
throughout the primary and secondary care sector.  
 
Data obtained from this East Midlands study differ greatly from those obtained previously even 
though the same methods were adopted. In 2001 the London study indicated that the crude 
prevalence was approximately one third of that reported here [2] (Table 6).  When 
standardised to the population of England this difference was reduced slightly to three times 
that observed in London, with adjusted rates for Derby City and South West London 4.15/1000 
and 1.55/1000 respectively.  It is unlikely that this difference can be attributed to 
methodological discrepancies or variations in the populations studied, as both samples were 
derived from an urban community.  It is possible that differences in characteristics of the 
population other than age and gender such as obesity may be partially responsible for the 
higher prevalence, particularly as the elderly and obese have reduced mobility and often have 
long term conditions.   Other findings were comparable to the earlier London study [2], for 
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example, the prevalence of CO was much higher amongst women than man.  It was also more 
prevalent amongst the obese and was highest amongst people over 85 years.  
 
Analysis of the subsets for which site of swelling was identified (889 patients identified) 
indicates that the proportion of patients with lower limb oedema was much higher in Derby 
City compared with South West London (Table 7). This may have occurred as a result of the 
higher awareness of CO locally or an increase in referrals of patients with lower limb oedema 
to the Derby service compared with South West London.  If this is the case, some of the 
difference in overall estimated prevalence could be attributed to greater identification of lower 
limb oedema rather than a real increase in overall prevalence.   
 
Nearly a third of the hospital in-patient population had CO which highlights that a number of 
conditions are associated with its occurrence and it can develop through a number of 
underlying pathophysiological mechanisms.  This finding also dispels the commonly held 
belief that CO is confined to community based populations and services.   Whilst it is well 
recognised that many community patients have venous leg ulceration, this study highlights 
that many of these cases have concurrent CO, an association which has received scant 
attention previously.    
 
The East Midlands data support the hypothesis that obesity is a common problem amongst 
patients with CO in specialist services.  Whilst it is not certain why CO and obesity co-exist, a 
number of mechanisms have been postulated.  These include impaired lymphatic flow [11], 
chronic inflammation, elevated production of interstitial fluid and reduced mobility.  Obesity is 
also implicated in the development of CO amongst people with cancer [10] and those with 
other long term conditions, particularly those who are wheelchair users.   In a case record 
review of patients with spina bifida, for example, CO was common compared to the general 
population [12].   
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One limitation of this study is that comprehensive data could not be obtained from General 
Practices as diagnostic codes have not been created for CO in the UK health service.   Poor 
recognition and limited knowledge of CO may have limited the number of patients identified, 
particularly in nursing/residential home settings where opportunities for continuing education 
are limited and the proportion of qualified staff is low.  Of greater importance is the lack of 
awareness of CO amongst the general population, as this limits the number of people who 
present to health services.  It is very difficult to estimate the true percentage of the population 
that have CO, particularly as symptoms can develop at a relatively late stage.  A major strength 
of this study is that patients were surveyed in all public health service settings available to 
Derby City residents and all nursing/residential homes. 
 
Although it is probable that the true prevalence of CO is even higher than estimated here, the 
findings of this study clearly illustrate that CO presents a major public health concern which 
has implications for the delivery of many health and social services.    
 
Conclusions 
 
Chronic oedema was found to affect approximately 4 per thousand in an East Midlands 
population.  There was a clear rise in prevalence with increasing age and surprisingly nearly 
a third of in-patients had CO.  Primary lymphoedema affected only a minority of patients known 
to a specialist service.  In contrast, secondary causes of CO such as venous disease and 
immobility were common.   
 
As this study was undertaken in an urban population with well-established lymphoedema 
services and adopted very similar methods to an earlier study conducted in London, it appears 
that the prevalence of CO has risen during the last decade and this could be attributable to 
population ageing and a concomitant increase in the prevalence of long term conditions.  
Applying the prevalence figures from this study would indicate that there are at least 240,000 
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patients affected by CO in the UK.   Clearly, there is a need to undertake further studies using 
a variety of methodologies to determine how robust these estimates are in relation to different 
populations and in rural settings.  Finally, since CO was prevalent in all health care settings 
surveyed, this highlights the importance of inter-agency collaboration, and the need for clinical 
pathways which span primary and secondary care sectors. 
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Table 1:   Type and Sources of Data Collected in each Setting 
Data Sources Hospital 
Wards 
Specialist 
Lymphoedema 
Out-Patient Service 
Other  
Out-Patient 
Services 
Community  
Services 
 
     
Case Ascertainment  
(clinical examination –  
‘Pitting test’  for chronic oedema) 
✓ ✓ ✓ ✓ 
Demographic Details 
Clinical History  
(questionnaire) 
✓ ✓ ✓ ✓ 
Site of swelling 
(reported by health professionals) 
✓ ✓ ✓ ✓ 
Presence of Leg Ulceration 
(reported by health professionals) 
✓ ✓ ✓ ✓ 
Control of Swelling  
(reported by health professionals) 
 
✓ ✓ ✓ ✓ 
BMI  
(measured objectively when feasible) 
 ✓   
Specialist classification of  
oedema (clinical examination) 
 ✓   
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Table 2: Prevalence of Chronic Oedema and Response Rate for Questionnaires 
Administered in each Service 
 
Service 
 
Number of 
Questionnaires 
Distributed or 
Sites Contacted 
Number 
Responded 
Response 
Rate 
% 
 Number of 
Patients 
Identified 
 
Community Nursing 
Services 
214 214 100  171  
GP Practices 41 2 5  2  
Nursing and 
Residential Homes 
26 26 100  2  
Specialist Out-Patient 
Lymphoedema 
Service 
688 688 100  688# 
Non-Specialist 
Out-Patient  Services 
4 0 0  0 
Hospital In-Patients 
 
453 453 100  129 
 
# Includes 21 patients at risk with no oedema present   
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Table 3: Ascertainment of Patients with Chronic Oedema by Age in a Derby City 
Population in 2012 
 
Age Group 
(years) 
n Population* Estimated  
Prevalence 
(per 1,000) 
 
Whole group    
<5 1 16,700 0.06 
5-14 1 27,700 0.04 
15-44 81 108,200 0.75 
45-64 283 55,900 5.06 
65-74 199 19,300 10.31 
75-84 244 13,700 17.81 
85+ 161 5,600 28.75 
    
Total: 971$ 247,100 3.93 
         95%CI           (3.69-4.19) 
Women    
<5 1 8100 0.12 
5-14 1 13300 0.08 
15-44 55 53400 1.03 
45-64 197 27800 7.09 
65-74 129 9800 13.16 
75-84 169 7800 21.67 
85+ 113 3700 30.54 
    
Sub-total: 666$ 123900 5.37 
         95%CI           (4.98-5.79) 
Men    
<5 0 8600 0 
5-14 0 14400 0 
15-44 26 54800 0.47 
45-64 86 28100 3.06 
65-74 70 9500 7.37 
75-84 75 5900 12.71 
85+ 48 1900 25.26 
    
Sub-total: 305 123200 2.48 
   95%CI           (2.21-2.77) 
* Mid-2010 Population Estimates:  Quinary age groups for Primary Care Organisations in 
England; estimated resident population (experimental) obtained from ONS data [13].   
Rates given are per 1,000 population. $ age missing in one  patient. 
 
  
17 
 
Table 4: Underlying Cause of Chronic Oedema for Patients Attending  
The Specialist Out-Patient Lymphoedema Service 
 
Classification / Underlying Cause Number 
 
Percent 
   
   
Secondary oedema 246 38 
Obesity / reduced mobility 169 26 
Primary lymphoedema 80 12 
Venous disease 60 9 
Other 43 7 
Oedema of advanced cancer 13 2 
Lipoedema 8 1 
Heart Failure 7 1 
   
Awaiting diagnosis/classification 24 4 
Total 651  
Missing 16  
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Table 5: Body Mass Index (Kg/m2) and Risk of Co-Morbidities  
BMI Range Classification Risk of ** 
Co-Morbidities 
Frequency 
(n=361) 
Percent 
18.5-25.0 Normal Range Average 48 13 
 
25-29.9 Overweight 
 
Mildly 
Increased 
62 17 
30-39.9 Class I / II Moderate/ 
Severe 
160 44 
40+ Class III Very  
Severe 
91 25 
 
**   Mean Body Mass Index Situation and Trends [14] 
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Table 6: Estimated Prevalence of Chronic Oedema Assessed1 in Two Urban 
Populations2 and Decades3 
 
 Derby (2012) West London (2001) 
 
Age Group 
(years) 
n Population Prevalence 
(per 1,000) 
 
n Population 4 Prevalence 
(per 1,000) 
 
Women       
<5 1 8100 0.12 0 21100 0 
5-14 1 13300 0.08 1 32300 0.03 
15-44 55 53400 1.03 69 150600 0.46 
45-64 197 27800 7.09 249 61500 4.05 
65-74 129 9800 13.16 117 24600 4.75 
75-84 169 7800 21.67 141 18700 7.53 
85+ 113 3700 30.54 106 9000 11.73 
 665 123900 5.37 683 317800 2.15 
Men       
<5 0 8600 0 0 21900 0 
5-14 0 14400 0 0 34100 0 
15-44 26 54800 0.47 14 153300 0.09 
45-64 86 28100 3.06 33 59000 0.56 
65-74 70 9500 7.37 38 19100 1.99 
75-84 75 5900 12.71 39 10600 3.68 
85+ 48 1900 25.26 16 2800 5.75 
 305 123200 2.48 140 300800 0.47 
       
Total: 5 970 247100 3.93 (4.15) 823 618600 1.33 (1.55) 
 
1 The same procedures were adopted in each instance 
2 West London and Derby City, UK 
3 2001 and 2012 
4 Estimated population data have been rounded to the nearest 100 patients for 
consistency with Derby results. The total population is therefore slightly different from 
that reported in the original paper [7] 
5 Standardised rates adjusted to the population of England in 2010 [13] are given in 
parentheses  
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Table 7: Site of swelling  
Study Upper Limb 
Oedema 
Lower Limb 
oedema 
Derby City 177/889 (19.9%) 745/889 (83.8%) 
   
SW London 334/823 (40.5%) 476/823 (57.8%) 
   
 
 
